KURA FY 2023 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$815M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$849,000

Operating Income

-$166M

Net Income

-$153M

EPS (Diluted)

$-2.08

Cash Flow

Operating Cash Flow

-$125M

Free Cash Flow

-$125M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$449M

Total Liabilities

$52M

Stockholders' Equity

$397M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$849,000	$0	—
Operating Income	-$166M	-$140M	-18.5%
Net Income	-$153M	-$136M	-12.4%